These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23022419)
1. Contribution of imaging in polymyalgia rheumatica. Williams M; Jain S; Patil P; Dasgupta B Joint Bone Spine; 2013 Mar; 80(2):228-9. PubMed ID: 23022419 [No Abstract] [Full Text] [Related]
2. Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis. Camellino D; Morbelli S; Paparo F; Massollo M; Sambuceti G; Cimmino MA Rheumatology (Oxford); 2014 May; 53(5):809. PubMed ID: 24643523 [No Abstract] [Full Text] [Related]
3. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A Joint Bone Spine; 2013 Mar; 80(2):171-7. PubMed ID: 22749663 [TBL] [Abstract][Full Text] [Related]
4. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118 [TBL] [Abstract][Full Text] [Related]
9. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Takahashi H; Yamashita H; Kubota K; Miyata Y; Okasaki M; Morooka M; Takahashi Y; Kaneko H; Kano T; Mimori A Mod Rheumatol; 2015 Jul; 25(4):546-51. PubMed ID: 25401232 [TBL] [Abstract][Full Text] [Related]
10. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Camellino D; Cimmino MA Rheumatology (Oxford); 2012 Jan; 51(1):77-86. PubMed ID: 21565899 [TBL] [Abstract][Full Text] [Related]
11. Where does polymyalgia rheumatica end and giant cell arteritis begin? Lessons from positron emission tomography studies. Blockmans D Acta Clin Belg; 2012; 67(6):389-93. PubMed ID: 23340142 [No Abstract] [Full Text] [Related]
12. F-18 FDG PET/CT of polymyalgia rheumatica. Toriihara A; Seto Y; Yoshida K; Umehara I; Nakagawa T; Liu R; Iwamoto I Clin Nucl Med; 2009 May; 34(5):305-6. PubMed ID: 19387211 [No Abstract] [Full Text] [Related]
13. High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography. Cimmino MA; Camellino D; Paparo F; Morbelli S; Massollo M; Cutolo M; Sambuceti G Rheumatology (Oxford); 2013 Oct; 52(10):1865-72. PubMed ID: 23850896 [TBL] [Abstract][Full Text] [Related]
14. Use of Betrains A; Blockmans D PET Clin; 2020 Apr; 15(2):147-152. PubMed ID: 32145885 [TBL] [Abstract][Full Text] [Related]
15. Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica. Owen CE; Poon AMT; Lee ST; Yap LP; Zwar RB; McMenamin CM; Lam SKL; Liew DFL; Pathmaraj K; Kemp A; Scott AM; Buchanan RRC Rheumatology (Oxford); 2018 Feb; 57(2):345-353. PubMed ID: 29121248 [TBL] [Abstract][Full Text] [Related]
16. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092 [TBL] [Abstract][Full Text] [Related]
17. Sterno-clavicular involvement in polymyalgia rheumatica. Verhoeven F; Prati C; Guillot X; Boulahdour H; Wendling D Joint Bone Spine; 2016 May; 83(3):363-4. PubMed ID: 26494596 [No Abstract] [Full Text] [Related]
18. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment. Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600 [TBL] [Abstract][Full Text] [Related]